Apogee Therapeutics, Inc. Earnings Per Share (Basic)
Apogee Therapeutics, Inc. (APGE) reported Earnings Per Share (Basic) of -$1.14 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-10
- Apogee Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$1.14.
- Apogee Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$1.06.
- Apogee Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$1.03.
- Apogee Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$1.11.
- Apogee Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$4.22.
- Apogee Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$3.30.
- Apogee Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$3.36.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 5 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 8 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 11 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.14 10-Q · filed 2026-08-10 | -$2.20 10-Q · filed 2026-08-10 | -$3.24 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$4.34 derived: net income ÷ weighted average shares · filed 2026-08-10 | |||
| 2026-03-31 | -$1.06 10-Q · filed 2026-05-11 | -$2.09 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$3.19 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$4.32 derived: net income ÷ weighted average shares · filed 2026-08-10 | |||
| 2025-12-31 | -$1.03 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$2.13 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$3.26 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$4.22 10-K · filed 2026-03-02 | |||
| 2025-09-30 | -$1.11 10-Q · filed 2025-11-10 | -$2.24 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$3.19 10-Q · filed 2025-11-10 | -$4.36 derived: net income ÷ weighted average shares · filed 2026-08-10 | |||
| 2025-06-30 | -$1.13 10-Q · filed 2026-08-10 | -$2.08 10-Q · filed 2026-08-10 | -$3.25 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$4.12 derived: net income ÷ weighted average shares · filed 2026-08-10 | |||
| 2025-03-31 | -$0.95 10-Q · filed 2026-05-11 | -$2.12 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$2.99 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$3.59 derived: net income ÷ weighted average shares · filed 2026-05-11 | |||
| 2024-12-31 | -$1.17 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$2.04 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$2.64 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$3.30 10-K · filed 2026-03-02 | |||
| 2024-09-30 | -$0.86 10-Q · filed 2025-11-10 | -$1.46 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$2.11 10-Q · filed 2025-11-10 | -$2.77 derived: net income ÷ weighted average shares · filed 2026-03-02 | |||
| 2024-06-30 | -$0.60 10-Q · filed 2025-08-11 | -$1.24 10-Q · filed 2025-08-11 | -$1.89 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$2.41 derived: net income ÷ weighted average shares · filed 2026-03-02 | |||
| 2024-03-31 | -$0.64 10-Q · filed 2025-05-12 | -$1.29 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$1.82 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$2.86 derived: net income ÷ weighted average shares · filed 2026-03-02 | |||
| 2023-12-31 | -$0.66 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$1.17 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$2.27 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$3.36 10-K · filed 2026-03-02 | |||
| 2023-09-30 | -$0.51 10-Q · filed 2024-11-12 | -$1.72 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$3.04 10-Q · filed 2024-11-12 | ||||
| 2023-06-30 | -$3.78 10-Q · filed 2024-08-12 | -$6.28 10-Q · filed 2024-08-12 | |||||
| 2023-03-31 | -$2.51 10-Q · filed 2024-05-13 | ||||||
| 2022-12-31 | -$16.16 10-K · filed 2024-03-05 | ||||||
| 2022-09-30 | -$9.46 10-Q · filed 2023-11-13 | -$12.90 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$17.00 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | -$1.45 10-Q · filed 2023-08-28 | -$5.25 10-Q · filed 2023-08-28 |